This report aims to provide a comprehensive presentation of the global market for RNA Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Drugs. This report contains market size and forecasts of RNA Drugs in global, including the following market information:
Global RNA Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global RNA Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five RNA Drugs companies in 2022 (%)
The global RNA Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
siRNA Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of RNA Drugs include Pfizer, Roche, Sanofi-Aventis, Abbott Laboratories, Arrowhead Pharmaceuticals, Benitec Biopharma, Calimmune Inc, Dicerna and Gradalis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA Drugs Market Segment Percentages, by Type, 2022 (%)
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Global RNA Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Global RNA Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global RNA Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies RNA Drugs revenues share in global market, 2022 (%)
Key companies RNA Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies RNA Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA Drugs, market overview.
Chapter 2: Global RNA Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of RNA Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global RNA Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Drugs Overall Market Size
2.1 Global RNA Drugs Market Size: 2022 VS 2029
2.2 Global RNA Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global RNA Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top RNA Drugs Players in Global Market
3.2 Top Global RNA Drugs Companies Ranked by Revenue
3.3 Global RNA Drugs Revenue by Companies
3.4 Global RNA Drugs Sales by Companies
3.5 Global RNA Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 RNA Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers RNA Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Drugs Players in Global Market
3.8.1 List of Global Tier 1 RNA Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 RNA Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA Drugs Market Size Markets, 2022 & 2029
4.1.2 siRNA
4.1.3 ASO
4.1.4 miRNA
4.1.5 Nucleic Acid Aptamers
4.2 By Type - Global RNA Drugs Revenue & Forecasts
4.2.1 By Type - Global RNA Drugs Revenue, 2018-2023
4.2.2 By Type - Global RNA Drugs Revenue, 2024-2029
4.2.3 By Type - Global RNA Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global RNA Drugs Sales & Forecasts
4.3.1 By Type - Global RNA Drugs Sales, 2018-2023
4.3.2 By Type - Global RNA Drugs Sales, 2024-2029
4.3.3 By Type - Global RNA Drugs Sales Market Share, 2018-2029
4.4 By Type - Global RNA Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA Drugs Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Tuberculosis
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 By Application - Global RNA Drugs Revenue & Forecasts
5.2.1 By Application - Global RNA Drugs Revenue, 2018-2023
5.2.2 By Application - Global RNA Drugs Revenue, 2024-2029
5.2.3 By Application - Global RNA Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global RNA Drugs Sales & Forecasts
5.3.1 By Application - Global RNA Drugs Sales, 2018-2023
5.3.2 By Application - Global RNA Drugs Sales, 2024-2029
5.3.3 By Application - Global RNA Drugs Sales Market Share, 2018-2029
5.4 By Application - Global RNA Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global RNA Drugs Market Size, 2022 & 2029
6.2 By Region - Global RNA Drugs Revenue & Forecasts
6.2.1 By Region - Global RNA Drugs Revenue, 2018-2023
6.2.2 By Region - Global RNA Drugs Revenue, 2024-2029
6.2.3 By Region - Global RNA Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global RNA Drugs Sales & Forecasts
6.3.1 By Region - Global RNA Drugs Sales, 2018-2023
6.3.2 By Region - Global RNA Drugs Sales, 2024-2029
6.3.3 By Region - Global RNA Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America RNA Drugs Revenue, 2018-2029
6.4.2 By Country - North America RNA Drugs Sales, 2018-2029
6.4.3 US RNA Drugs Market Size, 2018-2029
6.4.4 Canada RNA Drugs Market Size, 2018-2029
6.4.5 Mexico RNA Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe RNA Drugs Revenue, 2018-2029
6.5.2 By Country - Europe RNA Drugs Sales, 2018-2029
6.5.3 Germany RNA Drugs Market Size, 2018-2029
6.5.4 France RNA Drugs Market Size, 2018-2029
6.5.5 U.K. RNA Drugs Market Size, 2018-2029
6.5.6 Italy RNA Drugs Market Size, 2018-2029
6.5.7 Russia RNA Drugs Market Size, 2018-2029
6.5.8 Nordic Countries RNA Drugs Market Size, 2018-2029
6.5.9 Benelux RNA Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia RNA Drugs Revenue, 2018-2029
6.6.2 By Region - Asia RNA Drugs Sales, 2018-2029
6.6.3 China RNA Drugs Market Size, 2018-2029
6.6.4 Japan RNA Drugs Market Size, 2018-2029
6.6.5 South Korea RNA Drugs Market Size, 2018-2029
6.6.6 Southeast Asia RNA Drugs Market Size, 2018-2029
6.6.7 India RNA Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America RNA Drugs Revenue, 2018-2029
6.7.2 By Country - South America RNA Drugs Sales, 2018-2029
6.7.3 Brazil RNA Drugs Market Size, 2018-2029
6.7.4 Argentina RNA Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa RNA Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa RNA Drugs Sales, 2018-2029
6.8.3 Turkey RNA Drugs Market Size, 2018-2029
6.8.4 Israel RNA Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia RNA Drugs Market Size, 2018-2029
6.8.6 UAE RNA Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RNA Drugs Major Product Offerings
7.1.4 Pfizer RNA Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche RNA Drugs Major Product Offerings
7.2.4 Roche RNA Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis RNA Drugs Major Product Offerings
7.3.4 Sanofi-Aventis RNA Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories RNA Drugs Major Product Offerings
7.4.4 Abbott Laboratories RNA Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Summary
7.5.2 Arrowhead Pharmaceuticals Business Overview
7.5.3 Arrowhead Pharmaceuticals RNA Drugs Major Product Offerings
7.5.4 Arrowhead Pharmaceuticals RNA Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Summary
7.6.2 Benitec Biopharma Business Overview
7.6.3 Benitec Biopharma RNA Drugs Major Product Offerings
7.6.4 Benitec Biopharma RNA Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Benitec Biopharma Key News & Latest Developments
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Summary
7.7.2 Calimmune Inc Business Overview
7.7.3 Calimmune Inc RNA Drugs Major Product Offerings
7.7.4 Calimmune Inc RNA Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Calimmune Inc Key News & Latest Developments
7.8 Dicerna
7.8.1 Dicerna Company Summary
7.8.2 Dicerna Business Overview
7.8.3 Dicerna RNA Drugs Major Product Offerings
7.8.4 Dicerna RNA Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Dicerna Key News & Latest Developments
7.9 Gradalis
7.9.1 Gradalis Company Summary
7.9.2 Gradalis Business Overview
7.9.3 Gradalis RNA Drugs Major Product Offerings
7.9.4 Gradalis RNA Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Gradalis Key News & Latest Developments
7.10 Quark
7.10.1 Quark Company Summary
7.10.2 Quark Business Overview
7.10.3 Quark RNA Drugs Major Product Offerings
7.10.4 Quark RNA Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Quark Key News & Latest Developments
7.11 RXi
7.11.1 RXi Company Summary
7.11.2 RXi RNA Drugs Business Overview
7.11.3 RXi RNA Drugs Major Product Offerings
7.11.4 RXi RNA Drugs Sales and Revenue in Global (2018-2023)
7.11.5 RXi Key News & Latest Developments
7.12 Senesco
7.12.1 Senesco Company Summary
7.12.2 Senesco RNA Drugs Business Overview
7.12.3 Senesco RNA Drugs Major Product Offerings
7.12.4 Senesco RNA Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Senesco Key News & Latest Developments
7.13 Silence Therapeutics
7.13.1 Silence Therapeutics Company Summary
7.13.2 Silence Therapeutics RNA Drugs Business Overview
7.13.3 Silence Therapeutics RNA Drugs Major Product Offerings
7.13.4 Silence Therapeutics RNA Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Silence Therapeutics Key News & Latest Developments
7.14 Silenseed
7.14.1 Silenseed Company Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNA Drugs Major Product Offerings
7.14.4 Silenseed RNA Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Silenseed Key News & Latest Developments
7.15 Tekmira
7.15.1 Tekmira Company Summary
7.15.2 Tekmira Business Overview
7.15.3 Tekmira RNA Drugs Major Product Offerings
7.15.4 Tekmira RNA Drugs Sales and Revenue in Global (2018-2023)
7.15.5 Tekmira Key News & Latest Developments
7.16 Alnylam Pharmaceuticals
7.16.1 Alnylam Pharmaceuticals Company Summary
7.16.2 Alnylam Pharmaceuticals Business Overview
7.16.3 Alnylam Pharmaceuticals RNA Drugs Major Product Offerings
7.16.4 Alnylam Pharmaceuticals RNA Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Global RNA Drugs Production Capacity, Analysis
8.1 Global RNA Drugs Production Capacity, 2018-2029
8.2 RNA Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RNA Drugs Supply Chain Analysis
10.1 RNA Drugs Industry Value Chain
10.2 RNA Drugs Upstream Market
10.3 RNA Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 RNA Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of RNA Drugs in Global Market
Table 2. Top RNA Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global RNA Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global RNA Drugs Revenue Share by Companies, 2018-2023
Table 5. Global RNA Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global RNA Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers RNA Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers RNA Drugs Product Type
Table 9. List of Global Tier 1 RNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global RNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global RNA Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global RNA Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global RNA Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global RNA Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global RNA Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global RNA Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global RNA Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global RNA Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global RNA Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global RNA Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global RNA Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global RNA Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global RNA Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global RNA Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America RNA Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America RNA Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America RNA Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America RNA Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe RNA Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe RNA Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe RNA Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe RNA Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia RNA Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia RNA Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia RNA Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia RNA Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America RNA Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America RNA Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America RNA Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America RNA Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa RNA Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa RNA Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa RNA Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa RNA Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer RNA Drugs Product Offerings
Table 48. Pfizer RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Roche Company Summary
Table 51. Roche RNA Drugs Product Offerings
Table 52. Roche RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Roche Key News & Latest Developments
Table 54. Sanofi-Aventis Company Summary
Table 55. Sanofi-Aventis RNA Drugs Product Offerings
Table 56. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi-Aventis Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories RNA Drugs Product Offerings
Table 60. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. Arrowhead Pharmaceuticals Company Summary
Table 63. Arrowhead Pharmaceuticals RNA Drugs Product Offerings
Table 64. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 66. Benitec Biopharma Company Summary
Table 67. Benitec Biopharma RNA Drugs Product Offerings
Table 68. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Benitec Biopharma Key News & Latest Developments
Table 70. Calimmune Inc Company Summary
Table 71. Calimmune Inc RNA Drugs Product Offerings
Table 72. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Calimmune Inc Key News & Latest Developments
Table 74. Dicerna Company Summary
Table 75. Dicerna RNA Drugs Product Offerings
Table 76. Dicerna RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Dicerna Key News & Latest Developments
Table 78. Gradalis Company Summary
Table 79. Gradalis RNA Drugs Product Offerings
Table 80. Gradalis RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Gradalis Key News & Latest Developments
Table 82. Quark Company Summary
Table 83. Quark RNA Drugs Product Offerings
Table 84. Quark RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Quark Key News & Latest Developments
Table 86. RXi Company Summary
Table 87. RXi RNA Drugs Product Offerings
Table 88. RXi RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. RXi Key News & Latest Developments
Table 90. Senesco Company Summary
Table 91. Senesco RNA Drugs Product Offerings
Table 92. Senesco RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Senesco Key News & Latest Developments
Table 94. Silence Therapeutics Company Summary
Table 95. Silence Therapeutics RNA Drugs Product Offerings
Table 96. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Silence Therapeutics Key News & Latest Developments
Table 98. Silenseed Company Summary
Table 99. Silenseed RNA Drugs Product Offerings
Table 100. Silenseed RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Silenseed Key News & Latest Developments
Table 102. Tekmira Company Summary
Table 103. Tekmira RNA Drugs Product Offerings
Table 104. Tekmira RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Tekmira Key News & Latest Developments
Table 106. Alnylam Pharmaceuticals Company Summary
Table 107. Alnylam Pharmaceuticals RNA Drugs Product Offerings
Table 108. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Alnylam Pharmaceuticals Key News & Latest Developments
Table 110. RNA Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 111. Global RNA Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 112. Global RNA Drugs Production by Region, 2018-2023 (K Units)
Table 113. Global RNA Drugs Production by Region, 2024-2029 (K Units)
Table 114. RNA Drugs Market Opportunities & Trends in Global Market
Table 115. RNA Drugs Market Drivers in Global Market
Table 116. RNA Drugs Market Restraints in Global Market
Table 117. RNA Drugs Raw Materials
Table 118. RNA Drugs Raw Materials Suppliers in Global Market
Table 119. Typical RNA Drugs Downstream
Table 120. RNA Drugs Downstream Clients in Global Market
Table 121. RNA Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. RNA Drugs Segment by Type in 2022
Figure 2. RNA Drugs Segment by Application in 2022
Figure 3. Global RNA Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global RNA Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global RNA Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. RNA Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by RNA Drugs Revenue in 2022
Figure 9. By Type - Global RNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global RNA Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global RNA Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global RNA Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global RNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global RNA Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global RNA Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global RNA Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global RNA Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global RNA Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global RNA Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global RNA Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America RNA Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America RNA Drugs Sales Market Share, 2018-2029
Figure 23. US RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe RNA Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe RNA Drugs Sales Market Share, 2018-2029
Figure 28. Germany RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia RNA Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia RNA Drugs Sales Market Share, 2018-2029
Figure 37. China RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America RNA Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America RNA Drugs Sales Market Share, 2018-2029
Figure 44. Brazil RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa RNA Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa RNA Drugs Sales Market Share, 2018-2029
Figure 48. Turkey RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE RNA Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global RNA Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production RNA Drugs by Region, 2022 VS 2029
Figure 54. RNA Drugs Industry Value Chain
Figure 55. Marketing Channels
